Jonathan B. Fitzgerald, Ph.D.

  • Associate at Snell & Wilmer L.L.P. (433 Attorneys)
  • One Arizona Center, 400 East Van Buren Street, Suite 1900, Phoenix, AZ 85004
    View Jonathan B. Fitzgerald, Ph.D.'s office location
  • Peer Reviews

    No Reviews
  • Profile Visibility [ i ]
    • #380 in weekly profile views out of 9,399 Attorneys in Phoenix, AZ
    • #45,940 in weekly profile views out of 1,822,356 total attorneys Overall


JB is a registered patent attorney and has a Ph.D. in Molecular Physiology. His primary practice area involves preparing and prosecuting patent applications in the biotechnology and the life sciences areas. He has prosecuted patents that cover a wide range of molecular biology and biochemical technologies including plasmid/vector technology, immunotherapy, small RNA technology, protein/protein interactions, DNA/protein interactions, drug delivery systems, HIV treatments, biologic and small molecule therapeutics, viral technology, cancer treatments, and antibody technology, among others. JB also has experience in prosecuting patents involving mechanical and telecommunication technologies. As part of his practice, JB helps manage worldwide patent portfolios, which requires prosecuting patents in a variety of different countries and jurisdictions throughout the world. JB’s practice also includes performing freedom to operate analysis and prosecuting trademark applications.

Prior to entering the field of patent law, JB spent about 10 years in biomedical research. He has published much of his work in a variety of peer-reviewed technical publications. His research included investigating biochemical pathways and molecular mechanisms in a wide range of physiological and pathological systems. As part of his research, JB worked with a number of different biochemical and molecular biological techniques including, ELISA, in-situ hybridization, immunohistochemistry, immunocytochemistry, immunoblotting, qPCR, luciferase assays, transfection and transduction assays, vector/plasmid technology, and nanoparticle technology, among others.

Representative Presentations and Publications

• Approaching Antibody Patents After Amgen V. Sanofi, Co-Author, Law360 (January 30, 2019)
• Time after Time, Co-Author, Intellectual Property Magazine (September 25, 2018)
• Non-coding RNA in ovarian development and function, Book Chapter Co-Author, Non-coding and the Reproductive System (2016)
• Roles of microRNA-21 and programmed cell death 4 in the pathogenesis of human uterine leiomyomas, Co-Author, Fertility and Sterility, 98:726-34 (2012)
• Molecular Pathogenesis of Achromatopsia in the Cone Cyclic Nucleotide-Gated Channel CNGA3 Subunit, Book Chapter Co-Author, Adv Exp Med Biol., 64:245-53 (2010)
• The disease-causing mutations in the carboxyl terminus of the cone-cyclic nucleotide-gated channel CNGA3 subunit alter the local secondary structure and interfere with the channel active conformational change, Co-Author, Biochemistry, 49(8):1628-39 (2010)
• Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina, Co-Author, PLoS One, 4(10):e7410 (2009)
• Functional Expression of Cone Cyclic Nucleotide-Gated Channel in Cone Photoreceptor Derived 661W cells, Book Chapter Co-Author, Adv Exp Med Biol., 613:327-34 (2008)
• Functional activity of Photoreceptor Cyclic Nucleotide-Gated channels is dependent on the integrity of Membrane Lipid Rafts, Co-Author, Biochemistry, 47(12):3677-87 (2008)
• Native Cone Photoreceptor Cyclic Nucleotide-Gated Channel is a heterotetrameric complex comprising CNGA3 and CNGB3: A study using cone-dominant retina of Nrl-/- Mice, Co-Author, J. Neurochem., 106(5):204-55 (2007)

Community Involvement

•Violinist at Episcopal Church of the Nativity

Other Professional Experience

•Knobbe, Martens, Olson & Bear, LLP, Associate (2016-2017), Summer Associate (2015)
•University of Kansas School of Law, Extern for University of Kansas Innovation and Collaboration (2015-2016)
•Birch, Stewart, Kolasch & Birch, LLP, Summer Associate (2014)
•University of Kansas Medical Center, Research Associate (2013-2014)
•Oklahoma University Health Sciences Center, Research Assistant (2005-2008)

Areas of Practice (3)

  • Intellectual Property and Technology
  • Life Sciences and Medical Technology
  • Patent Prosecution and Counseling

Education & Credentials

Contact Information:
University Attended:
University of Kansas Medical Center, Ph.D., Molecular and Integrative Physiology, Dissertation: "Novel Direct Targets and Functional Roles for MicroRNA-21 in Granulosa Cells and Human Uterine Leiomyomas", 2013; Emory University/Candler School of Theology, M.T.S., 2005; Southern Nazarene University, B.S./B.A., Biology/Chemistry and English, cum laude, 2003
Law School Attended:
University of Kansas School of Law, J.D., CALI Awards: Patent Practice, Higher Education and the Law, 2016
Year of First Admission:
Arizona; Supreme Court of Arizona; California; United States Patent and Trademark Office; Supreme Court of California

Professional Memberships and Activities

•American Bar Association
•American Intellectual Property Law Association


Peer Reviews

This lawyer does not have peer reviews.

*Peer Reviews provided before April 15, 2008 are not displayed.


Lex Mundi

Phoenix, Arizona

Loading gif
  • map pin 1
    Phoenix, AZ
    One Arizona Center , 400 East Van Buren Street, Suite 1900
    Phoenix, AZ 85004

    602.382.6383 Phone

    Get Directions

Contact Jonathan B. Fitzgerald, Ph.D.

Required Fields

Required Fields

By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.